aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
3.285
+0.185 (5.97%)
Apr 21, 2025, 4:00 PM EDT - Market closed
aTyr Pharma Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$18.60
Upside
+466.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +965.45% | Mar 14, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $16 | Buy | Initiates | $16 | +387.06% | Feb 18, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +965.45% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +965.45% | Dec 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +965.45% | Oct 29, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $17 | Buy | Initiates | $17 | +417.50% | Oct 4, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +173.97% | Sep 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +965.45% | Aug 15, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $16 | Buy | Reiterates | $16 | +387.06% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +965.45% | Aug 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +965.45% | Jul 22, 2024 |